SOURCE: ISTA Pharmaceuticals

ISTA Pharmaceuticals

August 18, 2011 07:30 ET

ISTA Pharmaceuticals to Present at Southern California Investor Conference and Stifel Nicolaus Annual Healthcare Conference

IRVINE, CA--(Marketwire - Aug 18, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced its executives will present at two conferences in August and September. Both conference presentations will be webcast and will be available at

Southern California Investor Conference
Monday, August 29, 2011 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
ISTA's Chief Financial Officer and Vice President Corporate Development Lauren Silvernail will make a formal presentation on the marketed products, pipeline and corporate strategy.

Stifel Nicolaus Annual Healthcare Conference
Wednesday, September 7, 2011 at 2:40 p.m. Eastern Time
ISTA's President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will conduct a fireside chat with Stifel analyst Annabel Samimy on the company's competitive position and corporate outlook, after which he will also respond to questions from the on-site audience.

To access the live audio broadcast of the presentations, or the subsequent archived recording, log onto Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.


ISTA Pharmaceuticals, Inc. is a fast growing and the fourth largest branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at

Contact Information